Skip to main content Accessibility help

Diet, diabetes and schizophrenia: Review and hypothesis

  • Malcolm Peet (a1)



Diabetes is more common in people with schizophrenia than in the general population.


To explore the possible reasons for the association between diabetes and schizophrenia.


Diet and other lifestyle factors in patients with schizophrenia were reviewed as risk factors for diabetes.


People with schizophrenia show features of the metabolic syndrome at the onset of illness, before treatment. They also eat a poor diet, take little exercise and have high rates of smoking. Food intake may be increased further by antipsychotic medication. Nutritional factors appear to have a key role in the development of diabetes in patients with schizophrenia and may also affect the outcome and severity of schizophrenia. A common pathway through which diet might contribute to the development of both diabetes and schizophrenia is proposed.


Lifestyle factors may influence outcomes in both diabetes and schizophrenia. Lifestyle interventions are the key to improving the long-term health of people with schizophrenia.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Diet, diabetes and schizophrenia: Review and hypothesis
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Diet, diabetes and schizophrenia: Review and hypothesis
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Diet, diabetes and schizophrenia: Review and hypothesis
      Available formats



Hide All
Bai, O., Chlan-Fourney, J., Bowen, R., et al (2003) Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. Journal of Neuroscience Research, 71, 127131.
Briffa, D. & Meehan, T. (1998) Weight changes during clozapine treatment. Australian and New Zealand Journal of Psychiatry, 32, 718721.
Broadbelt, K., Byne, W. & Jones, L. B. (2002) Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medical prefrontal cortex. Schizophrenia Research, 58, 7581.
Brown, S., Birtwistle, L. R. & Thompson, C. (1999) The unhealthy lifestyle of people with schizophrenia. Psychological Medicine, 29, 697701.
Brown, S., Barraclough, B. & Inskip, H. (2000) Causes of the excess mortality of schizophrenia. British Journal of Psychiatry, 177, 212217.
Chong, S. A., Tan, E. C., Tan, C. H., et al (2003) Smoking and tardive dyskinesia: lack of involvement of the CYPIA2 gene. Journal of Psychiatry and Neuroscience, 28, 185189.
Christensen, O. & Christensen, E. (1988) Fat consumption and schizophrenia. Acta Psychiatrica Scandinavica, 78, 587591.
Colagiuri, S. & Miller, J. B. (2002) The ‘carnivore connection’ – evolutionary aspects of insulin resistance. European Journal of Clinical Nutrition, 56 (suppl. 1), S30S35.
Cotman, C. W. & Berchtold, N. C. (2002) Exercise: a behavioural intervention to enhance brain health and plasticity. Trends in Neuroscience, 25, 295301.
Duan, W., Guo, Z., Jiang, H., et al (2003) Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor. Endocrinology, 144, 24462453.
Food and Agriculture Organization (2003) Food and Agriculture Organization of the United Nations Statistical Database.
Glenny, A. M., O'Meara, S., Melville, A., et al (1997) The treatment and prevention of obesity: a systematic review of the literature. International Journal of Obesity, 21, 715737.
Gorski, J. A., Zeiler, S. R., Tamowski, S., et al (2003) Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. Journal of Neuroscience, 23, 68566865.
Gothelf, D., Falk, B., Singer, P., et al (2002) Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. American Journal of Psychiatry, 159, 10551057.
Hagg, S., Soderberg, S., Ahren, B., et al (2001) Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics. Journal of Clinical Psychiatry, 62, 843848.
Henderson, L., Gregory, J. & Simon, G. (2002) The National Diet and Nutrition Survey: Adults Aged 19–65. London: Stationery Office.
Homel, P., Casey, D., Allison, D. B. (2002) Changes in body mass index for individuals with and without schizophrenia, 1987–1996. Schizophrenia Research, 55, 277284.
Hong, C.-J., Younger, W.-Y., Lin, C.-H., et al (2003) Association study of a brain-derived neurotrophic factor Val 66 Met polymorphism and clozapine response of schizophrenic patients. Neuroscience Letters, 349, 206208.
Hopper, K. & Wanderling, J. (2000) Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: results from ISOS, the WHO collaborative follow-up project. Schizophrenia Bulletin, 26, 835846.
Jablensky, A., Sartorius, N., Ernberg, G., et al (1992) Schizophrenia: Manifestations, Incidence and Course in Different Cultures. A World Health Organization Ten-country Study. Psychological Medicine Monograph Supplement 20. New York: Cambridge.
Jakes, R. W., Day, N. E., Khaw, K. T., et al (2003) Television viewing and low participation in vigorous recreation are independently associated with obesity and markers of cardiovascular disease risk: EPIC-Norfolk population-based study. European Journal of Clinical Nutrition, 57, 10891096.
Kaur, G. & Kulkarni, S. K. (2003) Studies of modulation of feeding behaviour by atypical antipsychotics in female mice. Progress in Neuropsychopharmacology and Biological Psychiatry, 26, 277285.
Kelly, C. & McCreadie, R. G. (1999) Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. American Journal of Psychiatry, 156, 17511757.
Lessman, V., Gottmann, K. & Malcangio, M. (2003) Neurotrophin secretion: current facts and future prospects. Progress in Neurobiology, 69, 341379.
Levin, E. D. & Rezvani, A. H. (2002) Nicotinic treatment for cognitive dysfunction. Current Drug Targets in CNS and Neurological Disorders, 1, 423431.
Mann, J. I. (2002) Diet and risk of coronary heart disease and type 2 diabetes. Lancet, 360, 783789.
McCreadie, R., Macdonald, E., Blacklock, C., et al (1998) Dietary intake of schizophrenic patients in Nithsdale, Scotland: a case-control study. BMJ, 317, 784785.
Meiers, R. L. (1973) Relative hypoglycaemia in schizophrenia. In Orthomolecular Psychiatry (eds Hawkings, D. & Pauling, L.), pp. 452462. San Francisco, CA: WH Freeman.
Mellor, J. E., Laugharne, J. D. E. & Peet, M. (1996) Omega-3 fatty acid supplementation in schizophrenic patients. Human Psychopharmacology, 11, 3946.
Molteni, R., Barnard, R. J., Ying, Z., et al (2002) A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience, 112, 803814.
Mukherjee, S., Schnur, D. B. & Reddy, R. (1989) Family history of type 2 diabetes in schizophrenic patients. Lancet, i, 495.
Nakagawa, T., Tsuchida, A., Itakura, Y., et al (2000) Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes, 49, 456–444.
O'Dea, K. (1991) Westernisation, insulin resistance and diabetes in Australian aborigines. Medical Journal of Australia, 155, 258264.
Parker, L., Lamont, N., Unwin, N., et al (2003) A life course study of risk for hyperinsulinaemia, dyslipidaemia and obesity (the central metabolic syndrome) at age 49–51 years. Diabetic Medicine, 20, 406415.
Patkar, A. A., Gopalakrishnan, R., Lundy, A., et al (2002) Relationships between tobacco smoking and positive and negative symptoms in schizophrenia. Journal of Nervous and Mental Disease, 190, 604610.
Peet, M. (2002) Essential fatty acids: theoretical aspects and treatment implications for schizophrenia and depression. Advances in Psychiatric Treatment, 8, 223229.
Peet, M. (2004) International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis. British Journal of Psychiatry in press.
Rimm, E. B., Chan, J., Stampfer, M. J., et al (1995) Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ, 310, 555559.
Ryan, M. C. M., Collins, P. & Thakore, J. H. (2003) Impaired fasting glucose tolerance in first-episode, drug-naïve patients with schizophrenia. American Journal of Psychiatry, 160, 284289.
Sernyak, M. J., Leslie, D. L. Alarcon, R. D., et al (2002) Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. American Journal of Psychiatry, 159, 561566.
Silverstone, T., Smith, G. & Goodall, E. (1988) Prevalence of obesity in patients receiving depot antipsychotics. British Journal of Psychiatry, 153, 214217.
Sowell, M. O., Mukhopadhyay, N., Cavazzoni, P., et al (2002) Hyperglycaemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone or placebo. Journal of Endocrinology and Metabolism, 87, 29182923.
Stokes, C. (2003) Dietary Sugar Intake and the Severity of Symptoms of Schizophrenia. MSc Thesis. Sheffield: University of Sheffield.
Szekeres, G., Juhasz, A., Rimanocay, A., et al (2003) The C270T polymorphism of the brain-derived neurotrophic factor is associated with schizophrenia. Schizophrenia Research, 65, 1518.
Tucker, K. L. & Buranapin, S. (2001) Nutrition and ageing in developing countries. Journal of Nutrition, 131, 2417S2423S.
Ukkola, O. & Bouchard, C. (2001) Clustering of metabolic abnormalities in obese individuals: the role of genetic factors. Annals of Medicine, 33, 7980.
Webster, M. J., Weikert, C. S., Herman, M. M., et al (2002) BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. Brain Research. Developmental Brain Research, 139, 139150.
Weickert, C. S., Hyde, T. M., Lipska, B. K., et al (2003) Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Molecular Psychiatry, 8, 592610.
Werneke, U., Taylor, D., Sanders, T. A. B., et al (2003) Behavioural management of antipsychotic-induced weight gain: a review. Acta Psychiatrica Scandinavica, 108, 252259.
World Health Organization (1979) Schizophrenia: An International Follow-up Study New Yok: John Wiley.
World Health Organization (2003) Diet, Nutrition and the Prevention of Chronic Diseasses. WHO Technical Report Series 916. Geneva: WHO.
Zabeau, L., Lavens, D., Peelman, F., et al (2003) The ins and outs of leptin receptor activation. FEBS Letters, 546, 4550.

Diet, diabetes and schizophrenia: Review and hypothesis

  • Malcolm Peet (a1)


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Diet, diabetes and schizophrenia: Review and hypothesis

  • Malcolm Peet (a1)
Submit a response


We encountered an error trying to retrieve eLetters for this article. Please try again or contact Customer Services


Reply to: Submit a response

Your details

Conflicting interests

Do you have any conflicting interests? *